- Authors:
-
- Eron, Joseph J ;
- Cooper, David A ;
- Steigbigel, Roy T ;
- Clotet, Bonaventura ;
- Gatell, Jose M ;
- Kumar, Princy N ;
- Rockstroh, Jurgen K ;
- Schechter, Mauro ;
- Markowitz, Martin ;
- Yeni, Patrick ;
- Loutfy, Mona R ;
- Lazzarin, Adriano ;
- Lennox, Jeffrey L ;
- Strohmaier, Kim M ;
- Wan, Hong ;
- Barnard, Richard Jo ;
- Nguyen, Bach-Yen T ;
- Teppler, Hedy ;
- Pedersen, Court
- Subtitle:
- final results of two randomised, placebo-controlled trials
- DOI:
- 10.1016/S1473-3099(13)70093-8
- Abstract:
- Two randomised, placebo-controlled trials-BENCHMRK-1 and BENCHMRK-2-investigated the efficacy and safety of raltegravir, an HIV-1 integrase strand-transfer inhibitor. We report final results of BENCHMRK-1 and BENCHMRK-2 combined at 3 years (the end of the double-blind phase) and 5 years (the end of the study).
- Type:
- Journal article
- Language:
- English
- Published in:
- Lancet Infectious Diseases (portuguese Edition), 2013, Vol 13, Issue 7, p. 587-596
- Main Research Area:
- Medical science
- Publication Status:
- Published
- Review type:
- Peer Review
- Submission year:
- 2013
- Scientific Level:
- Scientific
- ID:
- 242867079